Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes cancer therapeutics in the United Kingdom. It focuses on the generic oncology injectable products. The company sells generic oncology products comprising capecitabine, temozolomide, and erlotinib.

Similar securities

Based on sector and market capitalization

Report issue